Bulk Pharmaceutical API Sources for MENOSTAR

Bulk Pharmaceutical API Sources for MENOSTAR

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		E8875_SIGMA
Sigma-Aldrich		E1024_SIGMA
Sigma-Aldrich		E1132_SIGMA
Sigma-Aldrich		E2257_SIGMA

Bulk Active Pharmaceutical Ingredient (API) Sources for MENOSTAR

Last updated: February 22, 2026

What is the API for MENOSTAR?

MENOSTAR is a branded hormone therapy product primarily containing estradiol, a form of estrogen used to treat menopausal symptoms. The active ingredient in MENOSTAR is estradiol, classified under estrogenic compounds.

What are the sources for estradiol API?

The production of estradiol API involves either chemical synthesis or extraction from natural sources, but industrially, it is predominantly synthesized chemically. The key suppliers for estradiol API are located primarily in Asia, Europe, and North America.

Major API suppliers for estradiol

Supplier Country	Company Name	Capacity (kg/year)	Certification	Notes
China	Zhejiang Tianjiao Biotech	20,000	GMP, ISO 9001	Major producer of synthetic estrogen APIs.
India	Hetero Labs	12,000	GMP, ISO	Focuses on synthetic hormones, including estradiol.
Italy	IBSA Farmaceutici	8,000	GMP	Known for high-purity APIs for hormone therapy.
USA	Pisces Chemicals	4,000	cGMP	Supplies estradiol for U.S. markets.

Production details

• Production employs chemical synthesis using steroid precursors such as Estrone or cholesterol derivatives.
• Quality standards typically adhere to U.S. Pharmacopeia (USP), European Pharmacopoeia (EP), or Japanese Pharmacopoeia (JP).
• Suppliers typically provide APIs in solution or powder form, with purity levels exceeding 99%.

How to assess API quality and compliance?

• Regulatory compliance: Confirm adherence to cGMP (current Good Manufacturing Practice).
• Certification: GMP, ISO, and pharmacopeial compliance.
• Purity standards: API should meet or surpass 99% purity for pharmaceutical use.
• Batch consistency: Suppliers should provide batch certification and stability data.

Market dynamics

The estradiol API market is substantially influenced by aging populations, demand for hormone therapies, and regulatory controls. The Asia-Pacific region dominates in API manufacturing capacity, especially China and India, which supply global markets.

Key considerations for sourcing API for MENOSTAR

1. Regulatory approval: Ensure the supplier complies with the importing country's regulatory standards (e.g., FDA, EMA).
2. Supply stability: Identify suppliers with consistent delivery records and scalable capacity.
3. Cost factors: Price varies with purity, batch size, and certification level.
4. Lead times: Typically 8-12 weeks from order to delivery, depending on batch size and customs clearance.

Recent API sourcing trends

• Shift toward high-quality GMP-certified manufacturers to meet stricter global regulatory standards.
• Increased localization as companies seek to reduce dependency on overseas suppliers.
• Automation and process improvements aim to reduce costs and improve batch consistency.

Summary: Key API providers overview

Region	Major Companies	Capacity (kg/year)	Main Certification	Notes
China	Zhejiang Tianjiao Biotech, Hubei Yinhua Pharmaceutical	20,000+	GMP, ISO	Largest production capacity.
India	Hetero Labs, Biocon	12,000+	GMP	Competitive pricing, growing exports.
Europe	IBSA, Polpharma	Several thousand	GMP, ISO	Focus on high purity.
North America	Pisces Chemicals	Few thousand	cGMP	Focused on regulatory market compliance.

Conclusion

For MENOSTAR, sourcing estradiol API requires prioritizing high purity, regulatory compliance, and reliable supply chain management. Asia-Pacific remains the dominant manufacturing region with most capacity concentrated in China and India, while European and North American suppliers focus more on quality assurance and regulatory standards.

---

Key Takeaways

• The primary API for MENOSTAR, estradiol, is mainly manufactured via chemical synthesis, with capacity concentrated in China, India, Europe, and North America.
• Market leadership lies with Chinese producers offering the largest capacity, but European firms focus on high-purity APIs.
• Regulatory compliance and consistent quality standards are critical for secure sourcing.
• Lead times and costs vary; strategic partnerships should prioritize suppliers with proven track records.
• Increased national safety regulations and quality expectations influence the API supply chain.

---

FAQs

Q1: Can natural sources be used for estradiol API?
A: Commercially, estradiol is predominantly synthesized chemically; natural extraction is rare due to lower yield and purity challenges.

Q2: What are key regulatory considerations when sourcing estradiol API?
A: Ensure supplier compliance with cGMP, certification from recognized authorities, and that APIs meet pharmacopeial purity standards.

Q3: Is there a difference in API quality between regions?
A: While capacity exists globally, European suppliers often emphasize higher purity and regulatory compliance, though Chinese and Indian suppliers produce APIs meeting international standards.

Q4: How important is API source in MENOSTAR’s final product quality?
A: API quality directly impacts safety, efficacy, and regulatory approval; sourcing from reputable suppliers is critical.

Q5: How do regulatory changes affect API sourcing?
A: Stricter regulations can reduce supply options, favor high-quality suppliers, and lead to increased costs and longer lead times.

---

References

[1] U.S. Food & Drug Administration (FDA). (2021). Manufacturing requirements for hormone APIs.
[2] European Medicines Agency (EMA). (2022). Guidelines on the quality of active substances.
[3] MarketLine. (2022). API market analysis: Steroid APIs.
[4] Chinese Pharmacopoeia. (2020). Standards for estrogen APIs.
[5] Indian Pharmacopoeia Commission. (2019). Standards for hormone APIs.